Pre-Exposure Prophylaxis

Researchers identified ways that clinicians may be able to use electronic health records to identify candidates for HIV prevention medication.

On June 5, 1981, the CDC published an MMWR on five cases of Pneumocystis carinii pneumonia among previously healthy young men in Los Angeles, a report would later be recognized as the first cases of AIDS in the U.S. June 5, 2016 marked the 35th anniversary of this report.

The use of pre-exposure prophylaxis, or PrEP, in women is “a little bit more complicated” compared with men, according to Raphael J. Landovitz, MD, of the UCLA Center for Clinical AIDS Research and the David Geffen School of Medicine at UCLA.

ATLANTA — At the National HIV Prevention Conference, the CDC announced the release of a national HIV testing campaign and an online tool to help people assess their risk for acquiring HIV.

ATLANTA — Use of HIV pre-exposure prophylaxis may drive decisions about sex and condom use among serodiscordant couples, according to findings presented here at the CDC’s National HIV Prevention Conference.

ATLANTA — New cases of HIV infection in the United States dropped 19% from 2005 to 2014 due to continuing declines among several populations, according to data presented at the CDC’s National HIV Prevention Conference. However, the data suggested that gay and bisexual minorities and people residing in the South are disproportionately affected by HIV.

ATLANTA — Primary care clinicians frequently reported low awareness of pre-exposure prophylaxis, but once informed they often were interested in prescribing the treatment and pursuing education concerning its appropriate use, according to survey data presented at the CDC’s National HIV Prevention Conference.

With established evidence supporting the success of pre-exposure prophylaxis in preventing the spread of HIV, president of the International AIDS Society Chris Beyrer, MD, offers insight on various aspects of treatment that are essential for its efficacy.

In this video, Donna Sweet, MD, a professor of internal medicine at the University of Kansas Medical School-Wichita, discusses the latest developments from the International AIDS Conference 2024, including the major PURPOSE study.

In this video, Donna Sweet, MD, a professor of internal medicine at the University of Kansas Medical School-Wichita, discusses the current state of progress on a cure for HIV.